US$ 24.36
fda approval status of bpc 157 BPC-157 Status: Is It Approved for Human Use? If BPC-157 worked as well
Description
Why it was included in the FDA ban Research has not yet proven MOTS-C to deliver the above benefits
Critically, it does not bind to the growth hormone receptor and does not raise IGF-1 levels.[1] This means its effects stay localized to fat metabolism, making it a much more targeted option than full hGH therapy

Journal of cardiovascular pharmacology

Monsen et al., 2003)
Shallat, Todd A

Genesis1 has a broader, systemic approach
